4. AMF summary table

The table set out below, presented in the form recommended by the French Financial Markets Authority (AMF), clearly shows that there are no concurrent benefits under the suspended employment contract and the corporate oﬀice. It is also stated that the AMF considers that a company complies with the AFEP-MEDEF Code when it explains the maintenance of the employment contract of a corporate oﬀicer as an employee in the Company and his or her personal situation and provides detailed substantiation in this respect⁽¹⁾.

Tableau de synthèse AMF
	Employment contract		Supplementary pension scheme		Indemnities or benefits due or which may become due as a result of termination or change of duties		Indemnities relating to a non-compete clause
	Yes	No	Yes	No	Yes	No	Yes	No
Jean-Paul Agon Chairman of the Board		X		X		X		X
Nicolas Hieronimus Chief Executive Oﬀicer	X⁽¹⁾		X⁽²⁾			X⁽³⁾	X⁽⁴⁾

Nicolas Hieronimus has been a Director since 20 April 2021, and has served as Chief Executive Oﬀicer since 1 May 2021. Nicolas Hieronimus' employment contract is suspended for the entire length of his executive corporate oﬀice. This suspension was approved by the General Meeting on 20 April 2021.
Nicolas Hieronimus belongs to a Retirement Income Guarantee for Former Senior Executives scheme (Garantie de Ressources des Retraités Anciens Cadres Dirigeants), which is detailed in section 2.4.3.5. This defined benefit pension scheme makes the grant of benefits conditional on the beneficiary finishing his/her career in the company; L'Oréal does not finance them on an individual basis per employee.
No indemnity is due for termination of the corporate oﬀice. Under the employment contract, pursuant to the schedule of indemnities of the French National Collective Bargaining Agreement for the Chemicals Industry, in the event of dismissal, except in the event of gross misconduct or gross negligence, the dismissal indemnity may not be greater than 20 months of the remuneration payable under the employment contract (see section 2.4.3.4 on the cumulative amount of the contractual indemnity and the indemnity due in consideration of the non-compete clause).
In respect of the employment contract, pursuant to the provisions of the National Collective Bargaining Agreement for the Chemical Industries, in the event of termination of the employment contract (excluding voluntary or compulsory retirement), the indemnity due in consideration of the non-compete clause would be payable every month for two years on the basis of two thirds of the monthly fixed remuneration related to the employment contract unless the executive corporate oﬀicer were to be released from application of the clause (see section 2.4.3.4 on the accumulated amount of the convention indemnity and the indemnity due in consideration of the non-compete clause).

2.4.4 Summary table of the remuneration of Jean-Paul Agon, Chairman of the Board of Directors

2.4.4 Summary table of the remuneration of Jean-Paul Agon, Chairman of the Board of Directors
	2025		2024
In €	Amounts allocated	Amounts paid	Amounts allocated	Amounts paid
Fixed remuneration	950,000	950,000	1,166,667	1,166,667
Annual variable remuneration	-	-	-	-
Exceptional remuneration	-	-	-	-
Remuneration for term of oﬀice as a Director	-	-	-	-
Benefits in kind	-	-	-	-
TOTAL	950,000	950,000	1,166,667	1,166,667

SUMMARY TABLE OF REMUNERATION AND PERFORMANCE SHARES GRANTED TO JEAN-PAUL AGON, CHAIRMAN OF THE BOARD OF DIRECTORS

SUMMARY TABLE OF REMUNERATION AND PERFORMANCE SHARES GRANTED TO JEAN-PAUL AGON, CHAIRMAN OF THE BOARD OF DIRECTORS
In €	2025	2024
Remuneration due in respect of the financial year	Remuneration due in respect of the financial year 2025 950,000	Remuneration due in respect of the financial year 2024 1,166,667
Value of performance shares granted during the financial year	Value of performance shares granted during the financial year 2025 N/A	Value of performance shares granted during the financial year 2024 N/A
TOTAL	TOTAL 2025 950,000	TOTAL 2024 1,166,667

HISTORY OF THE STOCK OPTIONS GRANTED TO JEAN-PAUL AGON SINCE HIS APPOINTMENT AS A CORPORATE OFFICER THAT CAN STILL BE EXERCISED AT 31 DECEMBER 2025

N/A.

TABLE OF SHARE SUBSCRIPTION OR PURCHASE OPTIONS EXERCISED BY JEAN-PAUL DURING FINANCIAL YEAR 2025